A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies
Rasco, Drew W, Papadopoulos, Kyriakos P, Pourdehnad, Michael, Gandhi, Anita K, Hagner, Patrick R, Li, Yan, Wei, Xin, Chopra, Rajesh, Hege, Kristen, DiMartino, Jorge, Shih, Kent
Published in Clinical cancer research (01.01.2019)
Published in Clinical cancer research (01.01.2019)
Get full text
Journal Article
Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors
Tolcher, Anthony W, Sznol, Mario, Hu-Lieskovan, Siwen, Papadopoulos, Kyriakos P, Patnaik, Amita, Rasco, Drew W, Di Gravio, Donna, Huang, Bo, Gambhire, Dhiraj, Chen, Ying, Thall, Aron D, Pathan, Nuzhat, Schmidt, Emmett V, Chow, Laura Q M
Published in Clinical cancer research (15.09.2017)
Published in Clinical cancer research (15.09.2017)
Get full text
Journal Article
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
Patnaik, Amita, Rosen, Lee S, Tolaney, Sara M, Tolcher, Anthony W, Goldman, Jonathan W, Gandhi, Leena, Papadopoulos, Kyriakos P, Beeram, Muralidhar, Rasco, Drew W, Hilton, John F, Nasir, Aejaz, Beckmann, Richard P, Schade, Andrew E, Fulford, Angie D, Nguyen, Tuan S, Martinez, Ricardo, Kulanthaivel, Palaniappan, Li, Lily Q, Frenzel, Martin, Cronier, Damien M, Chan, Edward M, Flaherty, Keith T, Wen, Patrick Y, Shapiro, Geoffrey I
Published in Cancer discovery (01.07.2016)
Published in Cancer discovery (01.07.2016)
Get full text
Journal Article
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
Rasco, Drew W., Medina, Theresa, Corrie, Pippa, Pavlick, Anna C., Middleton, Mark R., Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S., Daud, Adil I., Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J.
Published in Cancer chemotherapy and pharmacology (01.07.2023)
Published in Cancer chemotherapy and pharmacology (01.07.2023)
Get full text
Journal Article
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
SHIMIZU, Toshio, TOLCHER, Anthony W, WICK, Michael J, ALVAREZ, Cathy, CAVAZOS, Aracely, MANGOLD, Gina L, PATNAIK, Amita, PAPADOPOULOS, Kyriakos P, BEERAM, Muralidhar, RASCO, Drew W, SMITH, Lon S, GUNN, Shelly, SMETZER, Leslie, MAYS, Theresa A, KAISER, Brianne
Published in Clinical cancer research (15.04.2012)
Published in Clinical cancer research (15.04.2012)
Get full text
Journal Article
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors
Naing, Aung, Papadopoulos, Kyriakos P, Autio, Karen A, Ott, Patrick A, Patel, Manish R, Wong, Deborah J, Falchook, Gerald S, Pant, Shubham, Whiteside, Melinda, Rasco, Drew R, Mumm, John B, Chan, Ivan H, Bendell, Johanna C, Bauer, Todd M, Colen, Rivka R, Hong, David S, Van Vlasselaer, Peter, Tannir, Nizar M, Oft, Martin, Infante, Jeffrey R
Published in Journal of clinical oncology (10.10.2016)
Published in Journal of clinical oncology (10.10.2016)
Get full text
Journal Article
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
Tao, Jessica J, Cangemi, Nicholas A, Makker, Vicky, Cadoo, Karen A, Liu, Joyce F, Rasco, Drew W, Navarro, Willis H, Haqq, Christopher M, Hyman, David M
Published in Clinical cancer research (15.09.2019)
Published in Clinical cancer research (15.09.2019)
Get full text
Journal Article
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
Tolcher, Anthony W., Patnaik, Amita, Papadopoulos, Kyriakos P., Rasco, Drew W., Becerra, Carlos R., Allred, Alicia J., Orford, Keith, Aktan, Gursel, Ferron-Brady, Geraldine, Ibrahim, Nageatte, Gauvin, Jennifer, Motwani, Monica, Cornfeld, Mark
Published in Cancer chemotherapy and pharmacology (01.01.2015)
Published in Cancer chemotherapy and pharmacology (01.01.2015)
Get full text
Journal Article
The LEAP program: lenvatinib plus pembrolizumab for the treatment of advanced solid tumors
Taylor, Matthew H, Schmidt, Emmett V, Dutcus, Corina, Pinheiro, Elaine M, Funahashi, Yasuhiro, Lubiniecki, Gregory, Rasco, Drew
Published in Future oncology (London, England) (01.02.2021)
Published in Future oncology (London, England) (01.02.2021)
Get full text
Journal Article
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier
Carpio, Cecilia, Bouabdallah, Reda, Ysebaert, Loïc, Sancho, Juan-Manuel, Salles, Gilles, Cordoba, Raul, Pinto, Antonio, Gharibo, Mecide, Rasco, Drew, Panizo, Carlos, Lopez-Martin, Jose A., Santoro, Armando, Salar, Antonio, Damian, Silvia, Martin, Alejandro, Verhoef, Gregor, Van den Neste, Eric, Wang, Maria, Couto, Suzana, Carrancio, Soraya, Weng, Andrew, Wang, Xuehai, Schmitz, Frank, Wei, Xin, Hege, Kristen, Trotter, Matthew W.B., Risueño, Alberto, Buchholz, Tonia J., Hagner, Patrick R., Gandhi, Anita K., Pourdehnad, Michael, Ribrag, Vincent
Published in Blood (26.03.2020)
Published in Blood (26.03.2020)
Get full text
Journal Article
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer
Patnaik, Amita, Haluska, Paul, Tolcher, Anthony W, Erlichman, Charles, Papadopoulos, Kyriakos P, Lensing, Janet L, Beeram, Muralidhar, Molina, Julian R, Rasco, Drew W, Arcos, Rebecca R, Kelly, Claudia S, Wijayawardana, Sameera R, Zhang, Xuekui, Stancato, Louis F, Bell, Robert, Shi, Peipei, Kulanthaivel, Palaniappan, Pitou, Celine, Mulle, Lynette B, Farrington, Daphne L, Chan, Edward M, Goetz, Matthew P
Published in Clinical cancer research (01.03.2016)
Published in Clinical cancer research (01.03.2016)
Get full text
Journal Article
Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors
Von Hoff, Daniel D, Rasco, Drew W, Heath, Elisabeth I, Munster, Pamela N, Schellens, Jan H M, Isambert, Nicolas, Le Tourneau, Christophe, O'Neil, Bert, Mathijssen, Ron H J, Lopez-Martin, Jose A, Edenfield, W Jeff, Martin, Miguel, LoRusso, Patricia M, Bray, Gordon L, DiMartino, Jorge, Nguyen, Aaron, Liu, Kejian, Laille, Eric, Bendell, Johanna C
Published in Clinical cancer research (01.09.2018)
Published in Clinical cancer research (01.09.2018)
Get full text
Journal Article
Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors
Shimizu, Toshio, LoRusso, Patricia M, Papadopoulos, Kyri P, Patnaik, Amita, Beeram, Muralidhar, Smith, Lon S, Rasco, Drew W, Mays, Theresa A, Chambers, Glenda, Ma, Anna, Wang, Jing, Laliberte, Robert, Voi, Maurizio, Tolcher, Anthony W
Published in Clinical cancer research (01.10.2014)
Published in Clinical cancer research (01.10.2014)
Get full text
Journal Article
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose–escalation phase 1 trial
Patnaik, Amita, Weiss, Glen J., Rasco, Drew W., Blaydorn, Lisa, Mirabella, Amy, Beeram, Murali, Guo, Wei, Lu, Sharon, Danaee, Hadi, McEachern, Kristen, Im, Ellie, Sachdev, Jasgit C.
Published in Cancer chemotherapy and pharmacology (01.01.2022)
Published in Cancer chemotherapy and pharmacology (01.01.2022)
Get full text
Journal Article
Efficacy and safety results of depatuxizumab mafodotin (ABT‐414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor
Goss, Glenwood D., Vokes, Everett E., Gordon, Michael S., Gandhi, Leena, Papadopoulos, Kyriakos P., Rasco, Drew W., Fischer, JuDee S., Chu, Katharine L., Ames, William W., Mittapalli, Rajendar K., Lee, Ho‐Jin, Zeng, Jiewei, Roberts‐Rapp, Lisa A., Loberg, Lise I., Ansell, Peter J., Reilly, Edward B., Ocampo, Christopher J., Holen, Kyle D., Tolcher, Anthony W.
Published in Cancer (15.05.2018)
Published in Cancer (15.05.2018)
Get full text
Journal Article
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis
Gupta, Neeraj, Hanley, Michael J., Venkatakrishnan, Karthik, Bessudo, Alberto, Rasco, Drew W., Sharma, Sunil, O'Neil, Bert H., Wang, Bingxia, Liu, Guohui, Ke, Alice, Patel, Chirag, Rowland Yeo, Karen, Xia, Cindy, Zhang, Xiaoquan, Esseltine, Dixie‐Lee, Nemunaitis, John
Published in Journal of clinical pharmacology (01.02.2018)
Published in Journal of clinical pharmacology (01.02.2018)
Get full text
Journal Article
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
LoRusso, Patricia, Ratain, Mark J., Doi, Toshihiko, Rasco, Drew W., de Jonge, Maja J. A., Moreno, Victor, Carneiro, Benedito A., Devriese, Lot A., Petrich, Adam, Modi, Dimple, Morgan-Lappe, Susan, Nuthalapati, Silpa, Motwani, Monica, Dunbar, Martin, Glasgow, Jaimee, Medeiros, Bruno C., Calvo, Emiliano
Published in Investigational new drugs (01.08.2022)
Published in Investigational new drugs (01.08.2022)
Get full text
Journal Article
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
Tolcher, Anthony W., Rodrigueza, Wendi V., Rasco, Drew W., Patnaik, Amita, Papadopoulos, Kyriakos P., Amaya, Alex, Moore, Timothy D., Gaylor, Shari K., Bisgaier, Charles L., Sooch, Mina P., Woolliscroft, Michael J., Messmann, Richard A.
Published in Cancer chemotherapy and pharmacology (01.02.2014)
Published in Cancer chemotherapy and pharmacology (01.02.2014)
Get full text
Journal Article
A Phase I Dose-Escalation and Dose-Expansion Study of FCN-437c, a Novel CDK4/6 Inhibitor, in Patients with Advanced Solid Tumors
Patnaik, Amita, Hamilton, Erika, Xing, Yan, Rasco, Drew W, Smith, Lon, Lee, Ya-Li, Fang, Steven, Wei, Jiao, Hui, Ai-Min
Published in Cancers (01.10.2022)
Published in Cancers (01.10.2022)
Get full text
Journal Article
619 First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: updated phase 1 results
Rasco, Drew, Razak, Albiruni Abdul, Laurie, Scott A, Diep, Anh, Glatt, Dylan M, Majeed, Sophia R, Kummar, Shivaani
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article